Multiple models explaining the pathogenesis of heart failure have been put forth during the
past 5 decades. These models were modified as clinical evidence supported or refuted their …

Coronavirus disease 2019 (COVID-19), the novel respiratory illness caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with severe morbidity and …

After its emergence in Wuhan, China, in late November or early December 2019, the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus rapidly spread globally. …

Multiple laboratory-developed tests (LDTs) and commercially available assays have emerged
to meet diagnostic needs related to the severe acute respiratory syndrome coronavirus 2 (…

With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative
anti-spike protein serological testing will likely become increasingly important. Here, we …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load on admission
was associated with a significantly increased 30-day mortality (odds ratio [OR], 4.20; 95% CI, …

Background SARS-CoV-2 testing demand has outpaced its supply. Pooling samples for
lower risk populations has the potential to accommodate increased demand for SARS-CoV-2 …

Herpes simplex viruses (HSVs) are difficult to sequence due to their large DNA genome,
high GC content, and the presence of repeats. To date, most HSV genomes have been …

Mass molecular diagnostic testing for the SARS-CoV-2 pandemic has drawn on laboratory
developed tests, commercial assays, and fully-automated platforms to accommodate …

Background Some mutations in the receptor binding domain of the SARS-CoV-2 Spike protein
are associated with increased transmission or substantial reductions in vaccine efficacy, …